Top Analyst Reports for SAP, Abbott Laboratories & Citigroup
https://www.zacks.com/commentary/2307996/top-analyst-reports-for-sap-abbott-laboratories-citigroup?cid=CS-ZC-FT-research_daily-2307996
Jul 24, 2024 - Today's Research Daily features new research reports on 16 major stocks, including SAP SE (SAP), Abbott Laboratories (ABT) and Citigroup Inc. (C), as well as two micro-cap stocks Team, Inc. (TISI) and Vaso Corporation (VASO).
0
Quest Diagnostics (DGX) Tops Q2 Earnings, Raises 2024 Outlook
https://www.zacks.com/stock/news/2306998/quest-diagnostics-dgx-tops-q2-earnings-raises-2024-outlook?cid=CS-ZC-FT-analyst_blog|earnings_article-2306998
Jul 23, 2024 - Quest Diagnostics (DGX) delivers impressive base business growth in the second quarter of 2024.
0
Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/07/18/abbott-laboratories-abt-q2-2024-earnings-call-tran/?source=iedfolrf0000001
Jul 18, 2024 - ABT earnings call for the period ending June 30, 2024.
0
Medtronic Loses 5% in a Month: What's Next for MDT Investors?
https://www.zacks.com/stock/news/2296266/medtronic-loses-5-in-a-month-what-s-next-for-mdt-investors?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2296266
Jul 02, 2024 - Medtronic's (MDT) stock suffers as a result of geopolitical complications and supply issues despite an expanding portfolio and strong strategic executions.
0
Abbott's (ABT) EPD Expansion Continues Despite FX Headwind
https://www.zacks.com/stock/news/2292370/abbott-s-abt-epd-expansion-continues-despite-fx-headwind?cid=CS-ZC-FT-analyst_blog|zer_report_update-2292370
Jun 24, 2024 - Banking on the successful execution of its Branded Generic operating model, Abbott's (ABT) EPD is well-positioned for sustained growth in many of the growing pharmaceutical markets.
0
Wall Street Analysts Think Abbott (ABT) Is a Good Investment: Is It?
https://www.zacks.com/stock/news/2292139/wall-street-analysts-think-abbott-abt-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2292139
Jun 24, 2024 - Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
0
Top Analyst Reports for Abbott, BP & Gilead
https://www.zacks.com/commentary/2291545/top-analyst-reports-for-abbott-bp-gilead?cid=CS-ZC-FT-research_daily-2291545
Jun 21, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), BP p.l.c. (BP) and Gilead Sciences, Inc. (GILD), as well as two micro-cap stocks Smith-Midland Corporation (SMID) and Crimson Wine Group, Ltd. (CWGL).
0
10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year
https://www.fool.com/investing/2024/06/20/10-stocks-to-build-a-dividend-portfolio-that-will/?source=iedfolrf0000001
Jun 20, 2024 - The power of compounding can build huge amounts of passive income.
0
Abbott's (ABT) AVEIR DR Leadless Pacemaker System Gains CE Mark
https://www.zacks.com/stock/news/2287251/abbott-s-abt-aveir-dr-leadless-pacemaker-system-gains-ce-mark?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2287251
Jun 12, 2024 - Abbott (ABT) receives a CE mark for AVEIR DR, the world's first dual chamber leadless pacemaker system.
0
Abbott (ABT) Gets FDA Nod for Two Glucose Monitoring Systems
https://www.zacks.com/stock/news/2287333/abbott-abt-gets-fda-nod-for-two-glucose-monitoring-systems?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2287333
Jun 12, 2024 - Abbott's (ABT) glucose monitoring systems - Lingo and Libre Rio - based on Freestyle Libre technology, receive FDA clearance.
0